These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32464483)

  • 1. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
    Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
    Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
    Shroff RT; Kennedy EB; Bachini M; Bekaii-Saab T; Crane C; Edeline J; El-Khoueiry A; Feng M; Katz MHG; Primrose J; Soares HP; Valle J; Maithel SK
    J Clin Oncol; 2019 Apr; 37(12):1015-1027. PubMed ID: 30856044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100334. PubMed ID: 33592563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
    Rizzo A; Brandi G
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine Extends Survival for Biliary Tract Cancer.
    Cancer Discov; 2017 Jul; 7(7):OF1. PubMed ID: 28572460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer.
    Rizzo A; Brandi G
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):547-554. PubMed ID: 33571059
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectives.
    Akhoundova Sanoyan D; McNamara MG; Lamarca A; Valle JW
    Curr Opin Oncol; 2020 Jul; 32(4):364-369. PubMed ID: 32541326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
    Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
    Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEOM clinical guidelines for pancreatic and biliary tract cancer (2020).
    Gómez-España MA; Montes AF; Garcia-Carbonero R; Mercadé TM; Maurel J; Martín AM; Pazo-Cid R; Vera R; Carrato A; Feliu J
    Clin Transl Oncol; 2021 May; 23(5):988-1000. PubMed ID: 33660222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
    Lamarca A; Edeline J; McNamara MG; Hubner RA; Nagino M; Bridgewater J; Primrose J; Valle JW
    Cancer Treat Rev; 2020 Mar; 84():101936. PubMed ID: 31986437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.
    Nara S; Esaki M; Ban D; Takamoto T; Mizui T; Shimada K
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):537-545. PubMed ID: 33793366
    [No Abstract]   [Full Text] [Related]  

  • 12. Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studies.
    Edeline J; Hirano S; Bertaut A; Konishi M; Benabdelghani M; Uesaka K; Watelet J; Ohtsuka M; Hammel P; Kaneoka Y; Joly JP; Yamamoto M; Monard L; Ambo Y; Louvet C; Ando M; Malka D; Nagino M; Phelip JM; Ebata T
    Eur J Cancer; 2022 Mar; 164():80-87. PubMed ID: 35182925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current therapy and future directions in biliary tract malignancies.
    Ciombor KK; Goff LW
    Curr Treat Options Oncol; 2013 Sep; 14(3):337-49. PubMed ID: 23686724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of adjuvant therapy for biliary tract cancer].
    Kato A; Miyazaki M
    Nihon Geka Gakkai Zasshi; 2014 Jul; 115(4):206-11. PubMed ID: 25154240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADJUBIL: phase II study of adjuvant immunotherapy with STRIDE regimen with/without capecitabine in biliary tract cancers.
    Goetze T; Gonzalez-Carmona MA; Kochen L; Agaoglu NB; Al-Batran SE; Habibzada T; Pons M; Brunner M; Ettrich TJ; Köhne CH; Roderburg C; Modest D
    Future Oncol; 2024 Feb; 20(6):307-315. PubMed ID: 38410920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials.
    Nakachi K; Gotohda N; Hatano E; Nara S; Takahashi S; Kawamoto Y; Ueno M
    Jpn J Clin Oncol; 2023 Nov; 53(11):1019-1026. PubMed ID: 37599063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Landmark Series: Gallbladder Cancer.
    Gamboa AC; Maithel SK
    Ann Surg Oncol; 2020 Aug; 27(8):2846-2858. PubMed ID: 32474816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of oral administration of cystine and theanine in patients with colorectal cancer undergoing capecitabine-based adjuvant chemotherapy after surgery: study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled, phase II trial.
    Hamaguchi R; Tsuchiya T; Miyata G; Sato T; Takahashi K; Ariyoshi K; Oyamada S; Iwase S
    BMJ Open; 2018 Jul; 8(7):e021442. PubMed ID: 30030317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
    Konishi M
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):301-5. PubMed ID: 22262202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intra and extra hepatic cholangiocarcinomas radiation therapy].
    Moreau J; Lapeyre M; Benoit C; Pezet D; Biau J
    Cancer Radiother; 2021 Apr; 25(2):175-181. PubMed ID: 33423966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.